Navigation Links
Warwick joins $3.4 million Anglo-Canadian quest for new weapons in war against antibiotic resistance

University of Warwick researchers have teamed up with Canadian scientists on a 2.2 million project to search for new antibiotics which will beat resistance in deadly "superbugs".

The University of Warwick is part of a transatlantic team funded by the Canada/UK Partnership on Antibiotic Resistance, a collaboration between the UK's Medical Research Council (MRC) and the Canadian Institutes of Health Research (CIHR).

The four-year project will support high-quality research into alternatives to existing antibiotics whose effectiveness is being challenged by increasing resistance in bacteria such as E. coli and MRSA.

Professor Chris Dowson, who is leading the project at the University of Warwick, said: "Growing antibiotic resistance to the current generation of antibiotics is of huge concern worldwide.

"Antibiotics underpin many aspects of healthcare - from cancer treatment through to surgery but the pace of antibiotic resistance in some bacteria is speeding up.

"Coupled with that, there is a worrying lack of new antibiotic drugs coming through the pipeline from private drug companies.

"That's why public funding for projects like this is so vital.

"Governments need to take responsibility for funding early-stage drug discovery as we face an increasing vacuum of antibiotic research within the pharmaceutical industry."

The Anglo-Canadian partnership takes advantage of the strong academic and clinical research strengths that exist in both Canada and the UK.

The University of Warwick is part of a team in the UK including the universities of Birmingham, Sheffield and Newcastle, working alongside the universities of Guelph, McMaster, Laval and British Columbia in Canada, which will focus on increasing understanding of bacterial cell wall growth in a bid to find new targets for new antibiotics.

Dr David Roper of the University of Warwick, School of Life Sciences and co-director of the project in the UK said: "Researchers on both sides of the Atlantic will be working in teams together exploring and exploiting aspects of the way in which bacteria synthesise their cell walls as they grow.

"Many current antibiotics, including penicillin, target this process and we think there are many new aspects to exploit, if we understood the process better.

"Our coordinated research efforts will be to further define the biological elements of how bacteria build their cell walls and discover new chemicals that interfere with that process.

"Research teams in Canada and the UK have unique facilities and expertise to do this and for the first time funding from MRC and CIHR is being used to combine those assets."

Research at the University of Warwick benefits from equipment provided through funding from Advantage West Midlands' Birmingham Science City, which will also contribute to this programme.


Contact: Anna Blackaby
University of Warwick

Related medicine news :

1. Warwick scientists discover how daughter cells receive the same number of chromosomes
2. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
3. AMA Joins First Lady in Fight Against Childhood Obesity
4. The West Clinic Joins Cancer Clinics of Excellence (CCE)
5. Orthopaedic Physician Dr. Brett Smith Joins Baptist Health Care as Total Joint Specialist
6. Longtime Quality Assurance Executive Randy Johnson Joins White Pine Systems as Vice President of Product Services
7. Peter Harker Joins Prometheus Research as Vice President of Sales
8. Tom Brunelle Joins StatCom as Enterprise VP, Northeast Region
9. Christina Hurnyak, Veteran Personal Injury Attorney, Joins Rudberg Law Offices, LLC
10. Don Blumenthal Joins White Pine Systems as Chief Compliance Officer
11. CURE Magazine Joins US Oncology
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: